Thermo Fisher Scientific (TMO) EBITDA margin US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA margin, % | ? | 31.6% | 33.1% | 26.2% | 26.6% | 25.2% | 24.6% | ||
Changes by years, y/y, % | +6pp | +1pp | -7pp | +0pp | -1pp | -0.3% |
Thermo Fisher Scientific. EBITDA margin, %
Thermo Fisher Scientific. EBITDA margin, changes, pp
Thermo Fisher Scientific (TMO) EBITDA margin US GAAP (quarter values) |
||||||||
2024Q1 | 2024Q2 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
EBITDA margin, % | ? | 24.8% | 25.5% | 28.2% | 17.3% | 27.4% | 24.6% | |
Changes by years, y/y, % | +0pp | -1pp | +2pp | -9pp | +1pp | |||
Changes by quarters, q/q, % | +0pp | +1pp | +3pp | -11pp | +10pp |